Astragaloside IV suppresses migration and invasion of TGF-β1-induced human hepatoma HuH-7 cells by regulating Nrf2/HO-1 and TGF-β1/Smad3 pathways

Astragaloside IV suppresses migration and invasion of TGF-β1-induced human hepatoma HuH-7 cells by regulating Nrf2/HO-1 and TGF-β1/Smad3 pathways
复制标题

黄芪甲苷 IV 通过调节 Nrf2/HO-1 和 TGF-β1/Smad3 途径抑制 TGF-β1 诱导的人肝癌 HuH-7 细胞的迁移和侵袭

DOI:
10.1007/s00210-021-02199-8
复制
发表时间:
2022-01
期刊:
Naunyn-Schmiedeberg's Archives of Pharmacology
影响因子:
--
通讯作者:
Pang Xiaonan
Pang Xiaonan
中科院分区:
其他
文献类型:
--
作者:
Li Lili;Wang Qin;He Yinghao;Sun Liangjie;Yang Yan;Pang Xiaonan

文献摘要

参考文献

相似文献

黄芪甲苷(AS-IV)是黄芪的主要有效成分之一,对多种恶性肿瘤有较好的抗肿瘤作用。氧化应激(OS)被认为是促进肝细胞癌(HCC)进展的关键因素。作为对OS的响应,核因子红细胞2相关因子2(Nrf 2)上调并诱导血红素加氧酶1(HO-1)以对抗氧化损伤。Smad 3羧基端的磷酸化(pSmad 3C)激活p21以抵抗HCC的进展,而Smad 3连接区的磷酸化(pSmad 3L)上调c-Myc的转录以发挥对HCC的促进作用。本研究旨在探讨AS-IV是否通过调节Nrf 2/HO-1和TGF-β1/Smad 3通路抑制人肝癌HuH-7细胞的迁移和侵袭。用TGF-β1(9或40 pM)诱导HuH-7细胞建立肝癌细胞模型,用不同浓度(5、10和20 μM)的AS-IV预处理24 h。测定细胞增殖、迁移、侵袭和细胞内活性氧(ROS)。检测Nrf 2、pSmad 3C、Nrf 2/pNrf 2、HO-1、pSmad 3C/3L、c-Myc和p21的表达。TGF-β 1可促进HuH-7细胞的增殖、迁移、侵袭和活性氧的产生。用AS-IV(5、10和20 μM)预处理显著降低HuH-7细胞的细胞增殖、迁移、侵袭和ROS产生。AS-IV还可上调Nrf 2/pNrf 2、HO-1、pSmad 3C和p21的表达,下调pSmad 3L和c-Myc的表达。结论:AS-Ⅳ抑制HuH-7细胞的迁移和侵袭,其机制可能与激活Nrf 2/HO-1通路,上调pSmad 3C/p21通路,下调pSmad 3L/c-Myc通路有关。目前的研究支持的概念,AS-IV可能是一个潜在的代理人治疗肝癌。
Astragaloside IV (AS-IV), one of the major compounds extract from Astragalus membranaceus, has shown attractive anti-cancer effects in certain malignancies. Oxidative stress (OS) is considered as a crucial factor in promoting the progression of hepatocellular carcinoma (HCC). In response to OS, nuclear factor erythroid 2-related factor 2 (Nrf2) upregulates and induces heme oxygenase 1 (HO-1) to combat oxidative damages. The phosphorylation of the COOH-terminal of Smad3 (pSmad3C) activates p21 to resist HCC progression, while the phosphorylation of the linker region of Smad3 (pSmad3L) up-regulates c-Myc transcription to exert promoting effect towards HCC. This study aimed to explore whether AS-IV suppresses migration and invasion of human hepatoma HuH-7 cells by regulating Nrf2/HO-1 and TGF-β1/Smad3 pathways. HuH-7 cells were induced with TGF-β1(9 or 40 pM) to establish HCC model in vitro and pretreated with AS-IV at different concentration (5, 10, and 20 μM) for 24 h. Cell proliferation, migration, invasion, and intracellular reactive oxygen species (ROS) of HuH-7 cells were measured. The expression of Nrf2, pSmad3C, Nrf2/pNrf2, HO-1, pSmad3C/3L, c-Myc, and p21 were detected. Exposure of HuH-7 cells to TGF-β1enhanced the cell proliferation, migration, invasion, and ROS production. Pretreatment with AS-IV (5, 10, and 20 μM) significantly reduced the cell proliferation, migration, invasion, and ROS production in HuH-7 cells. Furthermore, AS-IV increased the expressions of Nrf2/pNrf2, HO-1, pSmad3C, and p21, meanwhile reduced the expressions of pSmad3L and c-Myc. In conclusion, our study suggested that AS-IV inhibit HuH-7 cells migration and invasion, which related to activate Nrf2/HO-1 pathway, up-regulation pSmad3C/p21 pathway, and down-regulation pSmad3L/c-Myc pathway. The present research supports the notion that AS-IV may be a latent agent for the treatment of HCC.
CUL4B、NEDD4 和 UGT1As 参与肝细胞癌中的 TGF-β 信号转导。
DOI: 10.5604/16652681.1203154
发表时间: 2016
影响因子: 3.8
作者:
Zhaowei Qu;Di Li;Haitao Xu;Rujia Zhang;Bing Li;Chengming Sun;W. Dong;Yubao Zhang
通讯作者: Yubao Zhang
黄芪甲苷 IV 通过 AMPK 信号传导调节巨噬细胞极化来抑制肺癌进展和转移。
DOI: 10.1186/s13046-018-0878-0
发表时间: 2018-08-29
期刊: Journal of experimental & clinical cancer research : CR
影响因子: --
作者:
Xu F;Cui WQ;Wei Y;Cui J;Qiu J;Hu LL;Gong WY;Dong JC;Liu BJ
通讯作者: Liu BJ
DOI: 10.3748/wjg.v20.i35.12381
发表时间: 2014-09
影响因子: 4.3
作者:
Takashi Yamaguchi;Katsunori Yoshida;M. Murata;K. Matsuzaki
通讯作者: Takashi Yamaguchi;Katsunori Yoshida;M. Murata;K. Matsuzaki
DOI: 10.1016/j.biopha.2017.12.108
发表时间: 2018-03-01
影响因子: 7.5
作者:
Li, Yaling;Ye, Yun;Chen, Hongyan
通讯作者: Chen, Hongyan
星形镜IV通过激活NRF2信号途径来减轻小鼠乙酰氨基酚诱导的肝损伤。
DOI: 10.3390/molecules23082032
发表时间: 2018-08-14
期刊: Molecules (Basel, Switzerland)
影响因子: --
作者:
Li L;Huang W;Wang S;Sun K;Zhang W;Ding Y;Zhang L;Tumen B;Ji L;Liu C
通讯作者: Liu C